Thursday, July 31, 2014

EFSA Scrapie reduction unlikely without effective breeding programme

Scrapie reduction unlikely without effective breeding programme

 

30 July 2014

 

Over the last ten years Classical scrapie in sheep has decreased in countries where breeding programmes for resistance were effectively implemented, say EFSA experts.

 

EFSA has assessed the state of scrapie in the EU since the introduction ten years ago of a series of measures to monitor and control the disease. Scrapie is a fatal disease that affects sheep and goats. It belongs to the same family of diseases as bovine spongiform encephalopathy (BSE) which is found in cattle and is commonly known as mad cow disease. There is no evidence that scrapie has ever been transmitted to humans. The infectious agent is thought to be an abnormal form of a protein, also called a prion.

 

Experts of EFSA’s Panel on Biological Hazards have concluded that an eradication policy that relies only on the detection and culling of infected flocks and does not include breeding programmes for resistance is unlikely to succeed. This is both because of the characteristics of this disease and because the classical scrapie agent can persist in the environment for years.

 

“Sheep with a particular genetic makeup are resistant to Classical scrapie and breeding choices allow an increase in the flock’s resistance to the disease” explains Giuseppe Ru, Chair of EFSA’s Working Group on scrapie situation in the EU.

 

EFSA experts concluded that Classical scrapie in sheep may die out if the percentage of resistant sheep is above a certain threshold.

 

Occurrence of Classical scrapie varies greatly across the EU and its evolution over time should be considered country-by-country. Overall, it has been reported in 17 Member States; in some of them cases have decreased over time, while in others no clear trend was observed.

 

EFSA experts recommend strengthening surveillance activities to detect infected flocks and control the disease, increasing the implementation of breeding programmes for resistance in sheep and starting their use in goats too.

 

Scientific Opinion on the scrapie situation in the EU after 10 years of monitoring and control in sheep and goats

 

--------------------------------------------------------------------------------

 

Notes to editors:

 

Scrapie comes in two variants. Classical scrapie is transmitted through exposure to scrapie-infected animals (e.g. via milk or placentae) and their environment. Scientific evidence suggests that Atypical scrapie, the second variant, is spontaneous and non-contagious. In this opinion EFSA experts have considered both variants, with a particular focus on Classical scrapie. For media enquiries please contact: EFSA Media Relations Office Tel. +39 0521 036 149 E-mail: Press@efsa.europa.eu

 


 

INTRODUCTION - Surveillance (Part 1)

 

Regulatory Scrapie Slaughter Surveillance (RSSS)

 

RSSS started April 1, 2003. It is a targeted slaughter surveillance program which is designed to identify infected flocks. Samples have been collected from 430,085 animals since April 1, 2003. There have been 473 NVSL confirmed positive animals* (465 classical cases and 8 Nor98-like cases) since the beginning of RSSS. As of June 30, 2014, 32,173 samples have been collected in FY 2014, 26,408 from sheep and 5,765 from goats. As of June 30, 2014, 2 white-faced and 2 black-faced sheep have tested positive for scrapie in FY 2014. The percentage of samples that have tested positive for each face color from FY 2003 through FY 2014 is depicted in Chart 3. In November 2013, administrative units within APHIS Veterinary Services reorganized from 2 Regions to 6 Districts (Figure 1). The distribution of sheep and goat populations by District is depicted in Chart 4a. The number of animals collected for FY 2014 by District where collected is shown in Chart 4b. A monthly comparison of RSSS collections by fiscal year is displayed in Chart 5. Chart 6 is a retrospective 6-month rolling average of the percent positive, black-faced sheep sampled at RSSS collection sites.

 

*RSSS positives are reported based on collection date and may have been confirmed after June 30, 2014.

 

INTRODUCTION - Surveillance (Part 2) On-Farm Surveillance Testing sheep and goats in the field is an essential part of scrapie surveillance, and it includes both regulatory testing and on-farm surveillance. As the National Scrapie Eradication Program moves closer towards meeting the goal of identifying the last remaining cases of classical scrapie, finding and testing all sheep and goats meeting targeted sampling criteria is even more important. As of June 30, 2014, 1,174 sheep and 440 goats have been tested on-farm for FY 2014. As of June 30, 15 sheep and 9 goats have tested positive. The number of animals tested on-farm by month and by species for FY 2014 is shown in Chart 7. Total Animals Sampled for Scrapie Testing As of June 30, 2014, 33,787 animals have been sampled for scrapie testing:

 

•32,173 RSSS samples and 1,614 on-farm samples [includes regulatory testing (necropsy and live-animal) and on-farm surveillance] (Chart 8);

 

•Of which 27,582 were sheep and 6,205 were goats. Distribution of sampling by type (RSSS or on-farm) and by species is shown in Chart 9. http://www.aphis.usda.gov/animal_health/animal_diseases/scrapie/downloads/monthly_scrapie_report.pdf

 

Overall, all Nor98 isolates contained highly PK resistant PrPres aggregates, with the main PrPres being a non-glycosylated internal fragment, cleaved at both the N and C termini, which represent the distinctive biochemical feature of Nor98. This biochemical signature, unique among animal TSEs, is reminiscent of PrPres observed in human prion disorders such as GSS and VPSPr.

 

snip...

 

At present the only epidemiological link between animal and human TSEs has been demonstrated for classical BSE and variant CJD [16], [78], showing for the first time the zoonotic potential of TSEs. Since then, the implementation of active surveillance in livestock has led to the identification of Nor98 and other previously unrecognised animal prion strains, mainly with a sporadic occurrence, whose origin and zoonotic potential are still poorly understood [79]. It has been previously shown that peripheral tissues of sheep with Nor98 might harbour detectable levels of infectivity [49], [50], indicating that infectious material might enter the food chain. On the other hand, the well known genetic aetiology of GSS suggests that the similar PrPSc conformations found in Nor98 and GSS P102L are unlikely to indicate a common infectious source, but might derive from a similar molecular mechanisms involved in PrPC-to-PrPSc conversion.

 

snip...

 

Citation: Pirisinu L, Nonno R, Esposito E, Benestad SL, Gambetti P, et al. (2013) Small Ruminant Nor98 Prions Share Biochemical Features with Human Gerstmann-Sträussler-Scheinker Disease and Variably Protease-Sensitive Prionopathy. PLoS ONE 8(6): e66405. doi:10.1371/journal.pone.0066405

 

Editor: Corinne Ida Lasmezas, The Scripps Research Institute Scripps Florida, United States of America

 

Received: January 24, 2013; Accepted: May 6, 2013; Published: June 24, 2013

 

Copyright: © 2013 Pirisinu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Funding: This work was supported by grants from the Italian Ministry of Health (RF-2009-1474624); the European Union (Neuroprion Network of Excellence CT-2004–506579); the National Institutes of Health (NIH) NS062787, NIH AG-08012, AG-14359; Alliance BioSecure, as well as the Center for Disease Control and Prevention Contract UR8/CCU515004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

 

Competing interests: The authors have declared that no competing interests exist.

 


 

*** The discovery of previously unrecognized prion diseases in both humans and animals (i.e., Nor98 in small ruminants) demonstrates that the range of prion diseases might be wider than expected and raises crucial questions about the epidemiology and strain properties of these new forms. We are investigating this latter issue by molecular and biological comparison of VPSPr, GSS and Nor98.

 

VARIABLY PROTEASE-SENSITVE PRIONOPATHY IS TRANSMISSIBLE ...price of prion poker goes up again $

 

OR-10: Variably protease-sensitive prionopathy is transmissible in bank voles

 

Romolo Nonno,1 Michele Di Bari,1 Laura Pirisinu,1 Claudia D’Agostino,1 Stefano Marcon,1 Geraldina Riccardi,1 Gabriele Vaccari,1 Piero Parchi,2 Wenquan Zou,3 Pierluigi Gambetti,3 Umberto Agrimi1 1Istituto Superiore di Sanità; Rome, Italy; 2Dipartimento di Scienze Neurologiche, Università di Bologna; Bologna, Italy; 3Case Western Reserve University; Cleveland, OH USA

 

Background. Variably protease-sensitive prionopathy (VPSPr) is a recently described “sporadic”neurodegenerative disease involving prion protein aggregation, which has clinical similarities with non-Alzheimer dementias, such as fronto-temporal dementia. Currently, 30 cases of VPSPr have been reported in Europe and USA, of which 19 cases were homozygous for valine at codon 129 of the prion protein (VV), 8 were MV and 3 were MM. A distinctive feature of VPSPr is the electrophoretic pattern of PrPSc after digestion with proteinase K (PK). After PK-treatment, PrP from VPSPr forms a ladder-like electrophoretic pattern similar to that described in GSS cases. The clinical and pathological features of VPSPr raised the question of the correct classification of VPSPr among prion diseases or other forms of neurodegenerative disorders. Here we report preliminary data on the transmissibility and pathological features of VPSPr cases in bank voles.

 

Materials and Methods. Seven VPSPr cases were inoculated in two genetic lines of bank voles, carrying either methionine or isoleucine at codon 109 of the prion protein (named BvM109 and BvI109, respectively). Among the VPSPr cases selected, 2 were VV at PrP codon 129, 3 were MV and 2 were MM. Clinical diagnosis in voles was confirmed by brain pathological assessment and western blot for PK-resistant PrPSc (PrPres) with mAbs SAF32, SAF84, 12B2 and 9A2.

 

Results. To date, 2 VPSPr cases (1 MV and 1 MM) gave positive transmission in BvM109. Overall, 3 voles were positive with survival time between 290 and 588 d post inoculation (d.p.i.). All positive voles accumulated PrPres in the form of the typical PrP27–30, which was indistinguishable to that previously observed in BvM109 inoculated with sCJDMM1 cases.

 

In BvI109, 3 VPSPr cases (2 VV and 1 MM) showed positive transmission until now. Overall, 5 voles were positive with survival time between 281 and 596 d.p.i.. In contrast to what observed in BvM109, all BvI109 showed a GSS-like PrPSc electrophoretic pattern, characterized by low molecular weight PrPres. These PrPres fragments were positive with mAb 9A2 and 12B2, while being negative with SAF32 and SAF84, suggesting that they are cleaved at both the C-terminus and the N-terminus. Second passages are in progress from these first successful transmissions.

 

Conclusions. Preliminary results from transmission studies in bank voles strongly support the notion that VPSPr is a transmissible prion disease. Interestingly, VPSPr undergoes divergent evolution in the two genetic lines of voles, with sCJD-like features in BvM109 and GSS-like properties in BvI109.

 

The discovery of previously unrecognized prion diseases in both humans and animals (i.e., Nor98 in small ruminants) demonstrates that the range of prion diseases might be wider than expected and raises crucial questions about the epidemiology and strain properties of these new forms. We are investigating this latter issue by molecular and biological comparison of VPSPr, GSS and Nor98.

 


 

Wednesday, March 28, 2012

 

VARIABLY PROTEASE-SENSITVE PRIONOPATHY IS TRANSMISSIBLE, price of prion poker goes up again $

 


 

Thursday, October 10, 2013

 

CJD REPORT 1994 increased risk for consumption of veal and venison and lamb

 


 

*** The discovery of previously unrecognized prion diseases in both humans and animals (i.e., Nor98 in small ruminants) demonstrates that the range of prion diseases might be wider than expected and raises crucial questions about the epidemiology and strain properties of these new forms. We are investigating this latter issue by molecular and biological comparison of VPSPr, GSS and Nor98.

 

Increased Atypical Scrapie Detections

 

Press reports indicate that increased surveillance is catching what otherwise would have been unreported findings of atypical scrapie in sheep. In 2009, five new cases have been reported in Quebec, Ontario, Alberta, and Saskatchewan. With the exception of Quebec, all cases have been diagnosed as being the atypical form found in older animals. Canada encourages producers to join its voluntary surveillance program in order to gain scrapie-free status. The World Animal Health will not classify Canada as scrapie-free until no new cases are reported for seven years. The Canadian Sheep Federation is calling on the government to fund a wider surveillance program in order to establish the level of prevalence prior to setting an eradication date. Besides long-term testing, industry is calling for a compensation program for farmers who report unusual deaths in their flocks.

 


 

Thursday, March 29, 2012

 

atypical Nor-98 Scrapie has spread from coast to coast in the USA 2012

 

NIAA Annual Conference April 11-14, 2011San Antonio, Texas

 


 

Monday, April 25, 2011

 

Experimental Oral Transmission of Atypical Scrapie to Sheep

 

Volume 17, Number 5-May 2011 However, work with transgenic mice has demonstrated the potential susceptibility of pigs, with the disturbing finding that the biochemical properties of the resulting PrPSc have changed on transmission (40).

 


 

Monday, December 14, 2009

 

Similarities between Forms of Sheep Scrapie and Creutzfeldt-Jakob Disease Are Encoded by Distinct Prion Types

 

(hmmm, this is getting interesting now...TSS)

 

Sporadic CJD type 1 and atypical/ Nor98 scrapie are characterized by fine (reticular) deposits,

 

see also ;

 

All of the Heidenhain variants were of the methionine/ methionine type 1 molecular subtype.

 


 

see full text ;

 

Monday, December 14, 2009

 

Similarities between Forms of Sheep Scrapie and Creutzfeldt-Jakob Disease Are Encoded by Distinct Prion Types

 


 

P03.141

 

Aspects of the Cerebellar Neuropathology in Nor98

 

Gavier-Widén, D1; Benestad, SL2; Ottander, L1; Westergren, E1 1National Veterinary Insitute, Sweden; 2National Veterinary Institute,

 

Norway Nor98 is a prion disease of old sheep and goats. This atypical form of scrapie was first described in Norway in 1998. Several features of Nor98 were shown to be different from classical scrapie including the distribution of disease associated prion protein (PrPd) accumulation in the brain. The cerebellum is generally the most affected brain area in Nor98. The study here presented aimed at adding information on the neuropathology in the cerebellum of Nor98 naturally affected sheep of various genotypes in Sweden and Norway. A panel of histochemical and immunohistochemical (IHC) stainings such as IHC for PrPd, synaptophysin, glial fibrillary acidic protein, amyloid, and cell markers for phagocytic cells were conducted. The type of histological lesions and tissue reactions were evaluated. The types of PrPd deposition were characterized. The cerebellar cortex was regularly affected, even though there was a variation in the severity of the lesions from case to case. Neuropil vacuolation was more marked in the molecular layer, but affected also the granular cell layer. There was a loss of granule cells. Punctate deposition of PrPd was characteristic. It was morphologically and in distribution identical with that of synaptophysin, suggesting that PrPd accumulates in the synaptic structures. PrPd was also observed in the granule cell layer and in the white matter. The pathology features of Nor98 in the cerebellum of the affected sheep showed similarities with those of sporadic Creutzfeldt-Jakob disease in humans.

 

***The pathology features of Nor98 in the cerebellum of the affected sheep showed similarities with those of sporadic Creutzfeldt-Jakob disease in humans.

 


 

PR-26

 

NOR98 SHOWS MOLECULAR FEATURES REMINISCENT OF GSS

 

R. Nonno1, E. Esposito1, G. Vaccari1, E. Bandino2, M. Conte1, B. Chiappini1, S. Marcon1, M. Di Bari1, S.L. Benestad3, U. Agrimi1 1 Istituto Superiore di Sanità, Department of Food Safety and Veterinary Public Health, Rome, Italy (romolo.nonno@iss.it); 2 Istituto Zooprofilattico della Sardegna, Sassari, Italy; 3 National Veterinary Institute, Department of Pathology, Oslo, Norway

 

Molecular variants of PrPSc are being increasingly investigated in sheep scrapie and are generally referred to as "atypical" scrapie, as opposed to "classical scrapie". Among the atypical group, Nor98 seems to be the best identified. We studied the molecular properties of Italian and Norwegian Nor98 samples by WB analysis of brain homogenates, either untreated, digested with different concentrations of proteinase K, or subjected to enzymatic deglycosylation. The identity of PrP fragments was inferred by means of antibodies spanning the full PrP sequence. We found that undigested brain homogenates contain a Nor98-specific PrP fragment migrating at 11 kDa (PrP11), truncated at both the C-terminus and the N-terminus, and not N-glycosylated. After mild PK digestion, Nor98 displayed full-length PrP (FL-PrP) and N-glycosylated C-terminal fragments (CTF), along with increased levels of PrP11. Proteinase K digestion curves (0,006-6,4 mg/ml) showed that FL-PrP and CTF are mainly digested above 0,01 mg/ml, while PrP11 is not entirely digested even at the highest concentrations, similarly to PrP27-30 associated with classical scrapie. Above 0,2 mg/ml PK, most Nor98 samples showed only PrP11 and a fragment of 17 kDa with the same properties of PrP11, that was tentatively identified as a dimer of PrP11. Detergent solubility studies showed that PrP11 is insoluble in 2% sodium laurylsorcosine and is mainly produced from detergentsoluble, full-length PrPSc. Furthermore, among Italian scrapie isolates, we found that a sample with molecular and pathological properties consistent with Nor98 showed plaque-like deposits of PrPSc in the thalamus when the brain was analysed by PrPSc immunohistochemistry. Taken together, our results show that the distinctive pathological feature of Nor98 is a PrP fragment spanning amino acids ~ 90-155. This fragment is produced by successive N-terminal and C-terminal cleavages from a full-length and largely detergent-soluble PrPSc, is produced in vivo and is extremely resistant to PK digestion.

 

*** Intriguingly, these conclusions suggest that some pathological features of Nor98 are reminiscent of Gerstmann-Sträussler-Scheinker disease.

 

119

 


 

A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes

 

Annick Le Dur*,?, Vincent Béringue*,?, Olivier Andréoletti?, Fabienne Reine*, Thanh Lan Laï*, Thierry Baron§, Bjørn Bratberg¶, Jean-Luc Vilotte?, Pierre Sarradin**, Sylvie L. Benestad¶, and Hubert Laude*,?? +Author Affiliations

 

*Virologie Immunologie Moléculaires and ?Génétique Biochimique et Cytogénétique, Institut National de la Recherche Agronomique, 78350 Jouy-en-Josas, France; ?Unité Mixte de Recherche, Institut National de la Recherche Agronomique-Ecole Nationale Vétérinaire de Toulouse, Interactions Hôte Agent Pathogène, 31066 Toulouse, France; §Agence Française de Sécurité Sanitaire des Aliments, Unité Agents Transmissibles Non Conventionnels, 69364 Lyon, France; **Pathologie Infectieuse et Immunologie, Institut National de la Recherche Agronomique, 37380 Nouzilly, France; and ¶Department of Pathology, National Veterinary Institute, 0033 Oslo, Norway

 

***Edited by Stanley B. Prusiner, University of California, San Francisco, CA (received for review March 21, 2005)

 

Abstract Scrapie in small ruminants belongs to transmissible spongiform encephalopathies (TSEs), or prion diseases, a family of fatal neurodegenerative disorders that affect humans and animals and can transmit within and between species by ingestion or inoculation. Conversion of the host-encoded prion protein (PrP), normal cellular PrP (PrPc), into a misfolded form, abnormal PrP (PrPSc), plays a key role in TSE transmission and pathogenesis. The intensified surveillance of scrapie in the European Union, together with the improvement of PrPSc detection techniques, has led to the discovery of a growing number of so-called atypical scrapie cases. These include clinical Nor98 cases first identified in Norwegian sheep on the basis of unusual pathological and PrPSc molecular features and "cases" that produced discordant responses in the rapid tests currently applied to the large-scale random screening of slaughtered or fallen animals. Worryingly, a substantial proportion of such cases involved sheep with PrP genotypes known until now to confer natural resistance to conventional scrapie. Here we report that both Nor98 and discordant cases, including three sheep homozygous for the resistant PrPARR allele (A136R154R171), efficiently transmitted the disease to transgenic mice expressing ovine PrP, and that they shared unique biological and biochemical features upon propagation in mice. *** These observations support the view that a truly infectious TSE agent, unrecognized until recently, infects sheep and goat flocks and may have important implications in terms of scrapie control and public health.

 


 

Monday, December 1, 2008

 

When Atypical Scrapie cross species barriers

 

Authors

 

Andreoletti O., Herva M. H., Cassard H., Espinosa J. C., Lacroux C., Simon S., Padilla D., Benestad S. L., Lantier F., Schelcher F., Grassi J., Torres, J. M., UMR INRA ENVT 1225, Ecole Nationale Veterinaire de Toulouse.France; ICISA-INlA, Madrid, Spain; CEA, IBiTec-5, DSV, CEA/Saclay, Gif sur Yvette cedex, France; National Veterinary Institute, Postboks 750 Sentrum, 0106 Oslo, Norway, INRA IASP, Centre INRA de Tours, 3738O Nouzilly, France.

 

Content

 

Atypical scrapie is a TSE occurring in small ruminants and harbouring peculiar clinical, epidemiological and biochemical properties. Currently this form of disease is identified in a large number of countries. In this study we report the transmission of an atypical scrapie isolate through different species barriers as modeled by transgenic mice (Tg) expressing different species PRP sequence.

 

The donor isolate was collected in 1995 in a French commercial sheep flock. inoculation into AHQ/AHQ sheep induced a disease which had all neuro-pathological and biochemical characteristics of atypical scrapie. Transmitted into Transgenic mice expressing either ovine or PrPc, the isolate retained all the described characteristics of atypical scrapie.

 

Surprisingly the TSE agent characteristics were dramatically different v/hen passaged into Tg bovine mice. The recovered TSE agent had biological and biochemical characteristics similar to those of atypical BSE L in the same mouse model. Moreover, whereas no other TSE agent than BSE were shown to transmit into Tg porcine mice, atypical scrapie was able to develop into this model, albeit with low attack rate on first passage.

 

Furthermore, after adaptation in the porcine mouse model this prion showed similar biological and biochemical characteristics than BSE adapted to this porcine mouse model. Altogether these data indicate.

 

(i) the unsuspected potential abilities of atypical scrapie to cross species barriers

 

(ii) the possible capacity of this agent to acquire new characteristics when crossing species barrier

 

These findings raise some interrogation on the concept of TSE strain and on the origin of the diversity of the TSE agents and could have consequences on field TSE control measures.

 


 

Friday, February 11, 2011

 

Atypical/Nor98 Scrapie Infectivity in Sheep Peripheral Tissues

 


 

Saturday, August 14, 2010

 

BSE Case Associated with Prion Protein Gene Mutation (g-h-BSEalabama) and VPSPr PRIONPATHY

 

(see mad cow feed in COMMERCE IN ALABAMA...TSS)

 


 

why do we not want to do TSE transmission studies on chimpanzees $

 

5. A positive result from a chimpanzee challenged severly would likely create alarm in some circles even if the result could not be interpreted for man. I have a view that all these agents could be transmitted provided a large enough dose by appropriate routes was given and the animals kept long enough. Until the mechanisms of the species barrier are more clearly understood it might be best to retain that hypothesis.

 

snip...

 

R. BRADLEY

 


 

1: J Infect Dis 1980 Aug;142(2):205-8

 

Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to nonhuman primates.

 

Gibbs CJ Jr, Amyx HL, Bacote A, Masters CL, Gajdusek DC.

 

Kuru and Creutzfeldt-Jakob disease of humans and scrapie disease of sheep and goats were transmitted to squirrel monkeys (Saimiri sciureus) that were exposed to the infectious agents only by their nonforced consumption of known infectious tissues. The asymptomatic incubation period in the one monkey exposed to the virus of kuru was 36 months; that in the two monkeys exposed to the virus of Creutzfeldt-Jakob disease was 23 and 27 months, respectively; and that in the two monkeys exposed to the virus of scrapie was 25 and 32 months, respectively. Careful physical examination of the buccal cavities of all of the monkeys failed to reveal signs or oral lesions. One additional monkey similarly exposed to kuru has remained asymptomatic during the 39 months that it has been under observation.

 

snip...

 

The successful transmission of kuru, Creutzfeldt-Jakob disease, and scrapie by natural feeding to squirrel monkeys that we have reported provides further grounds for concern that scrapie-infected meat may occasionally give rise in humans to Creutzfeldt-Jakob disease.

 

PMID: 6997404

 


 

Recently the question has again been brought up as to whether scrapie is transmissible to man. This has followed reports that the disease has been transmitted to primates. One particularly lurid speculation (Gajdusek 1977) conjectures that the agents of scrapie, kuru, Creutzfeldt-Jakob disease and transmissible encephalopathy of mink are varieties of a single "virus". The U.S. Department of Agriculture concluded that it could "no longer justify or permit scrapie-blood line and scrapie-exposed sheep and goats to be processed for human or animal food at slaughter or rendering plants" (ARC 84/77)" The problem is emphasised by the finding that some strains of scrapie produce lesions identical to the once which characterise the human dementias"

 

Whether true or not. the hypothesis that these agents might be transmissible to man raises two considerations. First, the safety of laboratory personnel requires prompt attention. Second, action such as the "scorched meat" policy of USDA makes the solution of the acrapie problem urgent if the sheep industry is not to suffer grievously.

 

snip...

 

76/10.12/4.6

 


 

Nature. 1972 Mar 10;236(5341):73-4.

 

Transmission of scrapie to the cynomolgus monkey (Macaca fascicularis).

 

Gibbs CJ Jr, Gajdusek DC.

 

Nature 236, 73 - 74 (10 March 1972); doi:10.1038/236073a0

 

Transmission of Scrapie to the Cynomolgus Monkey (Macaca fascicularis)

 

C. J. GIBBS jun. & D. C. GAJDUSEK

 

National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland

 

SCRAPIE has been transmitted to the cynomolgus, or crab-eating, monkey (Macaca fascicularis) with an incubation period of more than 5 yr from the time of intracerebral inoculation of scrapie-infected mouse brain. The animal developed a chronic central nervous system degeneration, with ataxia, tremor and myoclonus with associated severe scrapie-like pathology of intensive astroglial hypertrophy and proliferation, neuronal vacuolation and status spongiosus of grey matter. The strain of scrapie virus used was the eighth passage in Swiss mice (NIH) of a Compton strain of scrapie obtained as ninth intracerebral passage of the agent in goat brain, from Dr R. L. Chandler (ARC, Compton, Berkshire).

 


 


 

Suspect symptoms

 

What if you can catch old-fashioned CJD by eating meat from a sheep infected with scrapie?

 

28 Mar 01

 

Like lambs to the slaughter 31 March 2001 by Debora MacKenzie Magazine issue 2284. Subscribe and get 4 free issues. FOUR years ago, Terry Singeltary watched his mother die horribly from a degenerative brain disease. Doctors told him it was Alzheimer's, but Singeltary was suspicious. The diagnosis didn't fit her violent symptoms, and he demanded an autopsy. It showed she had died of sporadic Creutzfeldt-Jakob disease.

 

Most doctors believe that sCJD is caused by a prion protein deforming by chance into a killer. But Singeltary thinks otherwise. He is one of a number of campaigners who say that some sCJD, like the variant CJD related to BSE, is caused by eating meat from infected animals. Their suspicions have focused on sheep carrying scrapie, a BSE-like disease that is widespread in flocks across Europe and North America.

 

Now scientists in France have stumbled across new evidence that adds weight to the campaigners' fears. To their complete surprise, the researchers found that one strain of scrapie causes the same brain damage in mice as sCJD.

 

"This means we cannot rule out that at least some sCJD may be caused by some strains of scrapie," says team member Jean-Philippe Deslys of the French Atomic Energy Commission's medical research laboratory in Fontenay-aux-Roses, south-west of Paris. Hans Kretschmar of the University of Göttingen, who coordinates CJD surveillance in Germany, is so concerned by the findings that he now wants to trawl back through past sCJD cases to see if any might have been caused by eating infected mutton or lamb.

 

Scrapie has been around for centuries and until now there has been no evidence that it poses a risk to human health. But if the French finding means that scrapie can cause sCJD in people, countries around the world may have overlooked a CJD crisis to rival that caused by BSE.

 

Deslys and colleagues were originally studying vCJD, not sCJD. They injected the brains of macaque monkeys with brain from BSE cattle, and from French and British vCJD patients. The brain damage and clinical symptoms in the monkeys were the same for all three. Mice injected with the original sets of brain tissue or with infected monkey brain also developed the same symptoms.

 

As a control experiment, the team also injected mice with brain tissue from people and animals with other prion diseases: a French case of sCJD; a French patient who caught sCJD from human-derived growth hormone; sheep with a French strain of scrapie; and mice carrying a prion derived from an American scrapie strain. As expected, they all affected the brain in a different way from BSE and vCJD. But while the American strain of scrapie caused different damage from sCJD, the French strain produced exactly the same pathology.

 

"The main evidence that scrapie does not affect humans has been epidemiology," says Moira Bruce of the neuropathogenesis unit of the Institute for Animal Health in Edinburgh, who was a member of the same team as Deslys. "You see about the same incidence of the disease everywhere, whether or not there are many sheep, and in countries such as New Zealand with no scrapie." In the only previous comparisons of sCJD and scrapie in mice, Bruce found they were dissimilar.

 

But there are more than 20 strains of scrapie, and six of sCJD. "You would not necessarily see a relationship between the two with epidemiology if only some strains affect only some people," says Deslys. Bruce is cautious about the mouse results, but agrees they require further investigation. Other trials of scrapie and sCJD in mice, she says, are in progress.

 

People can have three different genetic variations of the human prion protein, and each type of protein can fold up two different ways. Kretschmar has found that these six combinations correspond to six clinical types of sCJD: each type of normal prion produces a particular pathology when it spontaneously deforms to produce sCJD.

 

But if these proteins deform because of infection with a disease-causing prion, the relationship between pathology and prion type should be different, as it is in vCJD. "If we look at brain samples from sporadic CJD cases and find some that do not fit the pattern," says Kretschmar, "that could mean they were caused by infection."

 

There are 250 deaths per year from sCJD in the US, and a similar incidence elsewhere. Singeltary and other US activists think that some of these people died after eating contaminated meat or "nutritional" pills containing dried animal brain. Governments will have a hard time facing activists like Singeltary if it turns out that some sCJD isn't as spontaneous as doctors have insisted.

 

Deslys's work on macaques also provides further proof that the human disease vCJD is caused by BSE. And the experiments showed that vCJD is much more virulent to primates than BSE, even when injected into the bloodstream rather than the brain. This, says Deslys, means that there is an even bigger risk than we thought that vCJD can be passed from one patient to another through contaminated blood transfusions and surgical instruments.

 


 

Sunday, December 12, 2010

 

EFSA reviews BSE/TSE infectivity in small ruminant tissues News Story 2 December 2010

 


 

Wednesday, January 18, 2012

 

Selection of Distinct Strain Phenotypes in Mice Infected by Ovine Natural Scrapie Isolates Similar to CH1641 Experimental Scrapie

 

Journal of Neuropathology & Experimental Neurology: February 2012 - Volume 71 - Issue 2 - p 140–147

 


 

Thursday, July 14, 2011

 

Histopathological Studies of "CH1641-Like" Scrapie Sources Versus Classical Scrapie and BSE Transmitted to Ovine Transgenic Mice (TgOvPrP4)

 


 

Wednesday, January 18, 2012

 

BSE IN GOATS CAN BE MISTAKEN FOR SCRAPIE

 

February 1, 2012

 


 

Thursday, December 23, 2010

 

Molecular Typing of Protease-Resistant Prion Protein in Transmissible Spongiform Encephalopathies of Small Ruminants, France, 2002-2009

 

Volume 17, Number 1 January 2011

 


 

Thursday, November 18, 2010

 

Increased susceptibility of human-PrP transgenic mice to bovine spongiform encephalopathy following passage in sheep

 


 

Monday, December 14, 2009

 

Similarities between Forms of Sheep Scrapie and Creutzfeldt-Jakob Disease Are Encoded by Distinct Prion Types

 

(hmmm, this is getting interesting now...TSS)

 

Sporadic CJD type 1 and atypical/ Nor98 scrapie are characterized by fine (reticular) deposits,

 

see also ;

 

All of the Heidenhain variants were of the methionine/ methionine type 1 molecular subtype.

 


 

see full text ;

 

Monday, December 14, 2009

 

Similarities between Forms of Sheep Scrapie and Creutzfeldt-Jakob Disease Are Encoded by Distinct Prion Types

 


 

Thursday, July 21, 2011

 

A Second Case of Gerstmann-Sträussler-Scheinker Disease Linked to the G131V Mutation in the Prion Protein Gene in a Dutch Patient Journal of Neuropathology & Experimental Neurology:

 

August 2011 - Volume 70 - Issue 8 - pp 698-702

 


 

Monday, April 25, 2011

 

Experimental Oral Transmission of Atypical Scrapie to Sheep

 

Volume 17, Number 5-May 2011

 


 

Sunday, April 18, 2010

 

SCRAPIE AND ATYPICAL SCRAPIE TRANSMISSION STUDIES A REVIEW 2010

 


 

Thursday, November 18, 2010

 

Increased susceptibility of human-PrP transgenic mice to bovine spongiform encephalopathy following passage in sheep

 


 

Wednesday, January 19, 2011

 

EFSA and ECDC review scientific evidence on possible links between TSEs in animals and humans Webnachricht 19 Januar 2011

 


 

Monday, June 27, 2011

 

Comparison of Sheep Nor98 with Human Variably Protease-Sensitive Prionopathy and Gerstmann-Sträussler-Scheinker Disease

 


 

Thursday, November 18, 2010

 

Increased susceptibility of human-PrP transgenic mice to bovine spongiform encephalopathy following passage in sheep

 


 

Wednesday, November 13, 2013

 

Atypical Scrapie Prions from Sheep and Lack of Disease in Transgenic Mice Overexpressing Human Prion Protein

 


 

PRION 2014 CONFERENCE

 

CHRONIC WASTING DISEASE CWD

 

A FEW FINDINGS ;

 

Conclusions. To our knowledge, this is the first established experimental model of CWD in TgSB3985. We found evidence for co-existence or divergence of two CWD strains adapted to Tga20 mice and their replication in TgSB3985 mice. Finally, we observed phenotypic differences between cervid-derived CWD and CWD/Tg20 strains upon propagation in TgSB3985 mice. Further studies are underway to characterize these strains.

 

We conclude that TSE infectivity is likely to survive burial for long time periods with minimal loss of infectivity and limited movement from the original burial site. However PMCA results have shown that there is the potential for rainwater to elute TSE related material from soil which could lead to the contamination of a wider area. These experiments reinforce the importance of risk assessment when disposing of TSE risk materials.

 

The results show that even highly diluted PrPSc can bind efficiently to polypropylene, stainless steel, glass, wood and stone and propagate the conversion of normal prion protein. For in vivo experiments, hamsters were ic injected with implants incubated in 1% 263K-infected brain homogenate. Hamsters, inoculated with 263K-contaminated implants of all groups, developed typical signs of prion disease, whereas control animals inoculated with non-contaminated materials did not.

 

Our data establish that meadow voles are permissive to CWD via peripheral exposure route, suggesting they could serve as an environmental reservoir for CWD. Additionally, our data are consistent with the hypothesis that at least two strains of CWD circulate in naturally-infected cervid populations and provide evidence that meadow voles are a useful tool for CWD strain typing.

 

Conclusion. CWD prions are shed in saliva and urine of infected deer as early as 3 months post infection and throughout the subsequent >1.5 year course of infection. In current work we are examining the relationship of prionemia to excretion and the impact of excreted prion binding to surfaces and particulates in the environment.

 

Conclusion. CWD prions (as inferred by prion seeding activity by RT-QuIC) are shed in urine of infected deer as early as 6 months post inoculation and throughout the subsequent disease course. Further studies are in progress refining the real-time urinary prion assay sensitivity and we are examining more closely the excretion time frame, magnitude, and sample variables in relationship to inoculation route and prionemia in naturally and experimentally CWD-infected cervids.

 

Conclusions. Our results suggested that the odds of infection for CWD is likely controlled by areas that congregate deer thus increasing direct transmission (deer-to-deer interactions) or indirect transmission (deer-to-environment) by sharing or depositing infectious prion proteins in these preferred habitats. Epidemiology of CWD in the eastern U.S. is likely controlled by separate factors than found in the Midwestern and endemic areas for CWD and can assist in performing more efficient surveillance efforts for the region.

 

Conclusions. During the pre-symptomatic stage of CWD infection and throughout the course of disease deer may be shedding multiple LD50 doses per day in their saliva. CWD prion shedding through saliva and excreta may account for the unprecedented spread of this prion disease in nature.

 

see full text and more ;

 

Monday, June 23, 2014

 

*** PRION 2014 CHRONIC WASTING DISEASE CWD

 


 

Thursday, July 03, 2014

 

*** How Chronic Wasting Disease is affecting deer population and what’s the risk to humans and pets?

 


 

Tuesday, July 01, 2014

 

*** CHRONIC WASTING DISEASE CWD TSE PRION DISEASE, GAME FARMS, AND POTENTIAL RISK FACTORS THERE FROM

 


 

Sunday, July 13, 2014

 

Louisiana deer mystery unleashes litigation 6 does still missing from CWD index herd in Pennsylvania Great Escape

 


 

Monday, July 28, 2014

 

*** Mitigating the Risk of Transmission and Environmental Contamination of Transmissible Spongiform Encephalopathies 2013 Annual Report

 


 

 

Transmissible Spongiform Encephalopathy TSE Prion Disease North America 2014

 

Transmissible Spongiform Encephalopathy TSE Prion Disease have now been discovered in a wide verity of species across North America. typical C-BSE, atypical L-type BASE BSE, atypical H-type BSE, atypical H-G BSE, of the bovine, typical and atypical Scrapie strains, in sheep and goats, with atypical Nor-98 Scrapie spreading coast to coast in about 5 years. Chronic Wasting Disease CWD in cervid is slowly spreading without any stopping it in Canada and the USA and now has mutated into many different strains. Transmissible Mink Encephalopathy TME outbreaks. These Transmissible Spongiform Encephalopathy TSE Prion Disease have been silently mutating and spreading in different species in North America for decades.

 

The USDA, FDA, et al have assured us of a robust Triple BSE TSE prion Firewall, of which we now know without a doubt, that it was nothing but ink on paper. Since the 1997 mad cow feed ban in the USA, literally tons and tons of banned mad cow feed has been put out into commerce, never to return, as late as December of 2013, serious, serious breaches in the FDA mad cow feed ban have been documented. The 2004 enhanced BSE surveillance program was so flawed, that one of the top TSE prion Scientist for the CDC, Dr. Paul Brown stated ; Brown, who is preparing a scientific paper based on the latest two mad cow cases to estimate the maximum number of infected cows that occurred in the United States, said he has "absolutely no confidence in USDA tests before one year ago" because of the agency's reluctance to retest the Texas cow that initially tested positive. see ; http://www.upi.com/Health_News/2006/03/15/Analysis-What-that-mad-cow-means/UPI-12841142465253/

 

The BSE surveillance and testing have also been proven to be flawed, and the GAO and OIG have both raised serious question as to just how flawed it has been (see GAO and OIG reports). North America has more documented TSE prion disease, in different documented species (excluding the Zoo BSE animals in the EU), then any other place on the Globe. This does not include the very likelihood that TSE prion disease in the domestic feline and canine have been exposed to high doses of the TSE prion disease vid pet food. To date, it’s still legal to include deer from cwd zone into pet food or deer food. Specified Risk Material i.e. SRM bans still being breach, as recently as just last month.

 

nvCJD or what they now call vCJD, another case documented in Texas last month, with very little information being released to the public on about this case? with still the same line of thought from federal officials, ‘it can’t happen here’, so another vCJD blamed on travel of a foreign animal disease from another country, while ignoring all the BSE TSE Prion risk factors we have here in the USA and Canada, and the time that this victim and others, do spend in the USA, and exposed to these risk factors, apparently do not count in any way with regard to risk factor. a flawed process of risk assessment.

 

sporadic CJD, along with new TSE prion disease in humans, of which the young are dying, of which long duration of illness from onset of symptoms to death have been documented, only to have a new name added to the pot of prion disease i.e. sporadic GSS, sporadic FFI, and or VPSPR. I only ponder how a familial type disease could be sporadic with no genetic link to any family member? when the USA is the only documented Country in the world to have documented two different cases of atypical H-type BSE, with one case being called atypical H-G BSE with the G meaning Genetic, with new science now showing that indeed atypical H-type BSE is very possible transmitted to cattle via oral transmission (Prion2014). sporadic CJD and VPSPR have been rising in Canada, USA, and the UK, with the same old excuse, better surveillance. You can only use that excuse for so many years, for so many decades, until one must conclude that CJD TSE prion cases are rising. a 48% incease in CJD in Canada is not just a blip or a reason of better surveillance, it is a mathematical rise in numbers. More and more we are seeing more humans exposed in various circumstance in the Hospital, Medical, Surgical arenas to the TSE Prion disease, and at the same time in North America, more and more humans are becoming exposed to the TSE prion disease via consumption of the TSE prion via deer and elk, cattle, sheep and goats, and for those that are exposed via or consumption, go on to further expose many others via the iatrogenic modes of transmission of the TSE prion disease i.e. friendly fire. I pondered this mode of transmission via the victims of sporadic FFI, sporadic GSS, could this be a iatrogenic event from someone sub-clinical with sFFI or sGSS ? what if?

 

Two decades have passed since Dr. Ironside first confirmed his first ten nvCJD victims in 1995. Ten years later, 2005, we had Dr. Gambetti and his first ten i.e. VPSPR in younger victims. now we know that indeed VPSPR is transmissible. yet all these TSE prion disease and victims in the USA and Canada are being pawned off as a spontaneous event, yet science has shown, the spontaneous theory has never been proven in any natural case of TSE prion disease, and scientist have warned, that they have now linked some sporadic CJD cases to atypical BSE, to atypical Scrapie, and to CWD, yet we don’t here about this in the public domain. We must make all human and animal TSE prion disease reportable in every age group, in ever state and internationally, we must have a serious re-evaluation and testing of the USA cattle herds, and we must ban interstate movement of all cervids. Any voluntary effort to do any of this will fail. Folks, we have let the industry run science far too long with regards to the TSE prion disease. While the industry and their lobbyist continues to funnel junk science to our decision policy makers, Rome burns. ...end

 

REFERENCES

 

 

Sunday, June 29, 2014

 

Transmissible Spongiform Encephalopathy TSE Prion Disease North America 2014

 


 

 

 

TSS

Friday, January 17, 2014

Annual report of the Scientific Network on BSE-TSE EFSA, Question No EFSA-Q-2013-01004, approved on 11 December 2013

TECHNICAL REPORT

 

Annual report of the Scientific Network on BSE-TSE 20131

 

European Food Safety Authority2, 3

 

European Food Safety Authority (EFSA), Parma, Italy

 

ABSTRACT

 

The EFSA Scientific Network on bovine spongiform encephalopathies and other transmissible spongiform encephalopathies (BSE-TSE) held its 8th meeting on 8 and 9 October 2013 in Parma. The meeting served as an opportunity to exchange scientific information on BSE-TSE related issues among EU Member States, countries from the European Free Trade Association, EFSA, the European Commission and ad hoc participants. In this occasion, ad hoc representation included the World Animal Health Organisation (OIE), the EU Reference Laboratory for Proteins in Feed and the OIE-EU Reference Laboratory for animal TSEs. The issues discussed ranged from individual Member State cases studies (i.e. investigation of a potential BSE-like case in a goat in Poland) to worldwide issues of common interest in the field of BSE-TSE (i.e. update on activities of the OIE). Opportunities for topics that could be shared in the future in this Network were also discussed, and the Network Members and Observers expressed their interest to continue having yearly meetings.

 

© European Food Safety Authority, 2013

 

KEY WORDS

 

network, BSE, TSE, meeting

 

1 On request from EFSA, Question No EFSA-Q-2013-01004, approved on 11 December 2013.

 

2 Correspondence: biohaz@efsa.europa.eu

 

3 Acknowledgement: EFSA wishes to thank the BSE-TSE Network: Medical University of Vienna – Institute of Neurology (Austria), Veterinary and Agrochemical Research Centre (Belgium and Luxembourg), National Veterinary Service (Bulgaria), Ministry of Agriculture, Forestry and Water Management and Croatian Veterinary Institute (Croatia), Veterinary Services Cyprus (Cyprus), State Veterinary Institute Jihlava (Czech Republic), DTU Vet National Veterinary Institute, Technical University of Denmark (Denmark), Veterinary and Food Board, Animal Health, Welfare and Feedingstuffs Department (Estonia), Finnish Food Safety Authority-EVIRA (Finland), French Agency for Food, Environmental and Occupational Safety (France), Federal Institute for Risk Assessment (BfR) and Friedrich-Loeffler Institute (Germany), Ministry of Rural Development and Food (Greece), Ministry of Agriculture and Rural Development (Hungary), Department of Agriculture, Fisheries and Food (Ireland), Istituto Zooprofilattico e Sperimentale del Piemonte, Liguria e Val d’Aosta (Italy), Food and Veterinary Service (Latvia), State Food and Veterinary Service (Lithuania), Officer for Risk Assessment and Research, Netherlands Food and Consumer Products Safety Authority, Ministry of Economic Affairs (the Netherlands), National Veterinary Research Institute (Poland), Ministry of Agriculture (Portugal), National Sanitary Veterinary and Food Safety Authority (Romania), State Veterinary and Food Administration (Slovak Republic), Veterinary Administration (Slovenia), Ministry of Agriculture, Food and Environment Affairs (Spain), Swedish Zoonoses Centre National Veterinary Institute (Sweden), Food Standards Agency (United Kingdom) for the preparatory work on this output, and the Observers: National Veterinary Institute (Norway), Swiss Federal Veterinary Office (Switzerland), Ministry of Health (Former Yugoslav Republic of Macedonia), Ministry of Agriculture and Rural Affairs (Turkey), National Food Authority (Albania), University of Sarajevo (Bosnia-Herzegovina), Veterinary Directorate (Montenegro), Food and Veterinary Agency (Kosovo under UN Security Council Resolution 1244), Ministry of Agriculture, Forestry and Water Management (Serbia) and the EU Reference Laboratory for Proteins in Feed, the EU Reference Laboratory for animal TSEs and the World Animal Health Organisation for the support provided to this output.

 

Annual Report of EFSA’s BSE-TSE Network

 

EFSA supporting publication 2013:EN-532 2

 

SUMMARY

 

Developing networking and stronger co-operation with the Member States (MSs) and strengthening EFSA’s relationship with its institutional partners (EU and international) and stakeholders are among key recommendations formulated by EFSA’s Management Board. In accordance with EFSA’s strategy for cooperation and networking with MSs, the Scientific Network on BSE-TSE was launched in 2006. The BSE-TSE Network had its first meeting in 2006, and following this one meeting per year has been held.

 

The main overall goals of the BSE-TSE Network are to: improve dialogue among participants; build mutual understanding of risk assessment principles; enhance knowledge on and confidence in the scientific assessments carried out in the EU; and provide increased transparency in the current process among MSs and EFSA. In turn, it aims to raise the harmonisation level of the risk assessments developed in the EU.

 

The BSE-TSE Network is currently composed as follows: Network Members representing 27 EU MSs (Malta has not appointed a representative to this Network) and Network Observers representing countries from the European Free Trade Association (EFTA), EU Candidate Countries and Potential EU Candidate Countries. The European Commission Directorate-General of Health and Consumers and of Research are also Observers in the Network.

 

The eighth meeting of the Network was held on 8 and 9 October 2013 in Parma. In this occasion, representatives from the World Animal Health Organisation (OIE), the EU Reference Laboratory for Proteins in Feed (EURL-AP) and the EU Reference Laboratory for animal TSEs (EURL-TSE) were also present.

 

Beyond exchanging information on the activities in the BSE-TSE field carried out by Network Members, Observers, the European Commission and EFSA since the last meeting, several specific issues were discussed in the 2013 meeting. Key discussions included: past and present perspectives of BSE and TSE in Croatia, a scientific update on the potential for transmissibility of non-prion protein misfolding diseases, a case study on the characterisation of a potential BSE-like isolate from a goat in Poland and updates on BSE-TSE related activities form the OIE, the EURL-AP and the EURL-TSE.

 

Following discussion on potential further issues to be considered within the frame of the Network, it was decided by the Members and Observers of the Network to continue meeting once per year and to use the available electronic tools for discussion and data exchange if needed.

 

Annual Report of EFSA’s BSE-TSE Network

 

EFSA supporting publication 2013:EN-532 3

 

TABLE OF CONTENTS

 

Abstract .................................................................................................................................................... 1

 

Summary .................................................................................................................................................. 2

 

Table of contents ...................................................................................................................................... 3

 

Background as provided by EFSA ........................................................................................................... 4

 

Terms of reference as provided by EFSA ................................................................................................ 4

 

Activities .................................................................................................................................................. 6

 

1. Follow-up from annual meeting 2012 ............................................................................................. 6

 

2. Annual meeting 2013 ....................................................................................................................... 6

 

3. Planned Network activities for 2014 ............................................................................................... 8

 

Annual Report of EFSA’s BSE-TSE Network

 

EFSA supporting publication 2013:EN-532 4

 

BACKGROUND AS PROVIDED BY EFSA

 

The European Food Safety Authority (EFSA) is the keystone of European Union (EU) risk assessment regarding food and feed safety, animal health and welfare, nutrition, plant protection and plant health. In close collaboration with national authorities and in open consultation with its stakeholders, EFSA provides independent and transparent scientific advice and clear communication on existing and emerging risks associated with the food chain. On request from the European Commission, European Parliament or Member States (MSs) or on its own initiative1 EFSA provides scientific opinions on issues falling under its remit.

 

The Scientific Panel on Biological Hazards (BIOHAZ) provides independent scientific advice on biological hazards in relation to food safety and food-borne diseases. This covers: Food-borne zoonoses (animal diseases transmissible to humans); Transmissible spongiform encephalopathies (BSE-TSEs); Food microbiology; Food hygiene and associated waste management issues.

 

The Panel is one of EFSA’s key drivers on work on BSE and TSE. It carries out risk assessments in order to produce scientific opinions and advice for risk managers. The Panel’s risk assessment work is based on reviewing scientific information and data in order to evaluate the risks posed by a given issue. This helps to provide a sound foundation for European policies and legislation and supports risk managers in taking effective and timely decisions.

 

Developing networking and stronger co-operation with the MSs and strengthening EFSA’s relationship with its institutional partners (EU and international) and stakeholders are among the key recommendations formulated by EFSA’s Management Board. In accordance with EFSA’s strategy for cooperation and networking with MSs, the BSE-TSE Scientific Network was launched in 2006. The BSE/TSE Network had its first meeting in 2006 and following this, one meeting per year.

 

The seventh meeting of the Network was held on 10 and 11 October 2012. Members representing the MSs were appointed by the EU MSs themselves through the Advisory Forum and the EFSA Focal Points.

 

TERMS OF REFERENCE AS PROVIDED BY EFSA

 

The main overall goals of the Scientific Network on BSE-TSE are to: improve dialogue among participants; build mutual understanding of risk assessment principles; enhance knowledge on and confidence in the scientific assessments carried out in the EU; and to provide increased transparency in the current process among MSs and EFSA. In turn, it aims to raise the harmonisation level of the risk assessments developed in the EU.

 

The Network strengthens the scientific cooperation on BSE-TSE. It aims at anticipating and reducing the duplication of activities and hence avoiding divergence of opinion. The Network is a privileged environment to share data and methodologies facilitating harmonisation of assessment practices and assist in anticipating emerging risks in the EU.

 

The specific objectives of the Scientific Network on BSE-TSE are: Identifying common themes and areas for mutual collaboration. Identifying and avoiding duplication and divergence of opinion.

 

Annual Report of EFSA’s BSE-TSE Network

 

EFSA supporting publication 2013:EN-532 5

 

Identification of experts in specific areas and on special issues. Sharing of data availability and quality. Strengthening cooperation amongst risk assessors and managers. Exchanging information between EFSA, MSs and other stakeholders. Strengthening communication between EFSA-MSs and Risk Assessment-Risk Managers -Stakeholders. Focusing attention on and streamlining of common research needs. Identifying potential emerging risks when addressing current issues.

EFSA may entrust to the Network certain tasks, in particular preparatory work for scientific opinions, scientific and technical assistance, and collection of data.

 

The activities of the Network should be recorded in meeting minutes. In addition, an Annual Report summarising the activities will be produced.

 

Annual Report of EFSA’s BSE-TSE Network

 

EFSA supporting publication 2013:EN-532 6

 

ACTIVITIES

 

1. Follow-up from annual meeting 2012

 

At the 2012 BSE-TSE Network meeting, the Members and Observers of the Network highlighted several issues of interest. In particular, those issues have been addressed as follows:

 

1. Update the repository in EFSA’s Sciencenet (extranet information exchange platform) with information and presentations shared during all the Network meetings held. This has been updated and will automatically be updated after each Network meeting.

 

2. Analyse the questionnaire-based survey launched following the 2012 Network meeting on issues to be consider in 2013 Network meeting. This has been done and the agenda of the 2013 meeting reflected the issues addressed by Network Members and Observers.

 

2. Annual meeting 2013

 

The annual meeting was held on 8 and 9 October 2013 in Parma, and was attended by representatives from 22 European Union (EU) Member States (MS) (Austria, Belgium and Luxembourg, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, France, Greece, Hungary, Ireland, Italy, Latvia, The Netherlands, Poland, Romania, Slovak Republic, Slovenia, Spain and United Kingdom) and two EFTA countries (Norway and Switzerland). The European Commission (DG SANCO) was also present at the meeting. Further ad hoc attendees to this meeting included: Dr. Stuart MacDiarmid (World Organisation for Animal Health (OIE)), Dr. Gilbert Berben (EU-Reference Laboratory for Animal Proteins in Feedingstuffs (EURL-APF)) and Dr. Marion Simmons (EU Reference Laboratory and OIE Reference Laboratory for animal TSE (EURL-TSE)). Apologies were received from Network Members from Denmark, Germany, Lithuania, Portugal and Sweden. Malta has not appointed a representative to this EFSA Network. Further apologies were received from Network Observers from the EU Candidate and Potential Candidate countries who were not able to join in this occasion: Albania, Bosnia-Herzegovina, Former Yugoslav Republic of Macedonia, Kosovo under UN Security Council Resolution 1244, Montenegro, Serbia and Turkey.

 

The following are key issues that were discussed: Past and present BSE and TSE perspectives in Croatia.

 

Croatia was welcomed to the Network as a Member in this special occasion, following the adhesion of Croatia to the EU. The representative from Croatia presented historical and current experiences on the approach to BSE and TSE surveillance and controls. Historical preparedness activities aiming at building TSE-testing capacity and knowledge on TSE controls were carried out with the support of different countries in the past, in particular of the UK. BSE surveillance in cattle Croatia has not identified any positive case. Regarding other animal TSEs, a case of Atypical scrapie in sheep has been identified in 2013.

 

 

*** Update on activities of the OIE in the field of BSE and other animal TSEs

 

 

The representative from the World Organisation for Animal Health (OIE) presented the activities of this organisation related to BSE and scrapie. A short description of the current BSE epidemiological situation was presented. Considerations about Atypical BSE and other animal TSEs were discussed. The OIE representative highlighted that there were no particular activities ongoing at OIE level regarding the differentiation of BSE based on strain characterisation (i.e. Classical BSE, Atypical BSE). Recent modifications in the BSE chapter of the Terrestrial Animal Health Code regarding small countries were discussed.

 

 

*** Further, it was addressed that recently discussions have being held at OIE level on Chronic Wasting Disease of cervids.

 

 

Annual Report of EFSA’s BSE-TSE Network

 

EFSA supporting publication 2013:EN-532 7

 

Scientific update on the potential for transmissibility of non-prion protein misfolding diseases

 

The representative from Austria updated the participants on scientific issues related to the prion-like behaviour of altered proteins (‘prionoids’). The state of the art of experimental and epidemiological evidence on the potential for transmissibility of non-TSE protein misfolding diseases was presented. Experimental evidence shows that there are proteins (e.g. Abeta amyloid, tau, alpha-synuclein) that can behave in a similar way to the prion protein in terms of in-vivo propagation when experimentally inoculated animal models. There is no epidemiological evidence that human to human transmission has occurred in cases other than prion disorders. *** Still, it is acknowledged that the epidemiological investigation of the occurrence of this hypothetical phenomenon is not straight forward.

 

Case study on the typing of a potential BSE-like isolate from a goat in Poland

 

The representative from Poland described the scientific, technical and procedural aspects for the typing of TSE isolates from small ruminants. Firstly, the description of the bases for BSE and Scrapie strain-differentiation where presented with detail. This included not only the laboratory methods used but also an indication of the criteria that is applied for the characterisation of TSE isolates in animals. Secondly, available results of the typing of a potential BSE-like isolate from a goat in Poland were shown with detail. The EURL-TSE Strain Typing Expert Group (STEG) has preliminary classified the strain as not BSE, but BSE could not be fully excluded. Inoculation studies employing bioassay are ongoing in order to gain further information on the characteristics of this strain.

 

The EFSA Cattle TSE Monitoring Model (C-TSEMM)

 

The BIOHAZ Secretariat provided a live demonstration of the functioning of the EFSA C-TSEMM. The impact of different monitoring options in the overall performance of a monitoring programme was modelled employing some fictitious scenarios. The practical demonstration on the functioning of the model was found interesting by the meeting participants.

 

Update on activities of the EU-Reference Laboratory for Animal Proteins in Feedingstuffs (EURL-AP)

 

The representative from the EURL-AP provided an update on the recent EU regulatory instruments on certain aspects of testing for animal proteins in feedingstuffs. In particular, aspects of the proficiency testing done before the new legislation entered into force and specific methodological issues were presented. Further, experiences regarding limitations and findings during the first months of the implementation of the new regulation were discussed.

 

Update on activities of the EU-Reference Laboratory and OIE-Reference Laboratory for TSEs (EURL-TSE)

 

The representative form the EURL-TSE presented the activities of this EU and OIE reference laboratory. The roles of this reference laboratory when acting as EURL or as OIE-RL were presented. The tasks and challenges addresses by the laboratory are very wide. These include, among others: keeping of TSE-related reference materials (i.e. tissues), participation in the rapid screening of tests and approval of minor testing kit changes and follow up of unusual samples with the STEG. A brief description of the current epidemiological situation in the EU and worldwide was presented. The issue of Atypical BSE in the context of the current BSE epidemiological situation was discussed, emphasising the need for characterising isolates which is now required by regulations in the EU. Further issues beyond TSE diagnostics were also presented in detail, in particular experimental research on clinical aspects of different types of TSEs in sheep.

 

Annual Report of EFSA’s BSE-TSE Network

 

EFSA supporting publication 2013:EN-532 8

 

Update on the activities of the European Commission in the field of BSE-TSE

 

The representative from DG-SANCO provided a comprehensive review of recent (completed and ongoing) risk-management activities in different BSE-TSE related fields, which are coordinated by this Directorate General of the European Commission. A short update on activities in the Directorate General on Research and Innovation was also presented.

 

In addition to these discussion topics, the participants exchanged information on the risk assessment activities carried out since the last meeting at MS level and in EFSA. Details on some recent and planned TSE-related scientific publications were shared, in particular from Belgium and France.

 

The minutes of this meeting are published on the BSE Network section of the EFSA website4.

 

3. Planned Network activities for 2014

 

The period covering the current Mandate of the EFSA Scientific Network on BSE-TSE is expiring by the end of 2013.

 

The BIOHAZ Secretariat presented a draft reviewed mandate and terms of reference for the Network. This review followed from an analysis made in EFSA aiming at harmonising networking activities, which took into account recommendations received from Members of EFSA Networks through a questionnaire circulated in fall 2012 from the Secretariat of the EFSA Unit on Advisory Forum and Scientific Cooperation. The revised mandate and terms of reference were endorsed by the Members of this Network with some minor changes. Following this, a new mandate from EFSA will be sought in order to request the continuation of the EFSA Scientific Network on BSE-TSE.

 

A discussion followed on issues for future consideration in the frame of this Network. These included the following:

 

Include the possibility for inviting representatives from other countries or international organisations in order to have first-hand information on issues related to BSE and other animal TSEs.

 

Give consideration to issues related to animal by-products and find points of common interest that could be considered in this Network or in a parallel EFSA Network.

 

Encourage further active participation of members and observers in the agenda of the 2014 meeting. The Members and Observers of the Network found that exchanging knowledge in the context of the meeting of this EFSA Network was overall useful.

 

Those considerations made will be taken into account in the EFSA Secretariat when proposing and preparing future activities of this Network.

 

The Network Members and Observers expressed their interest in continuing having a yearly meeting. It was noted that it was the last meeting Prof. Budka was attending as the Network representative for Austria. The Network gratefully acknowledged his contribution throughout these years.

 

 


 

(last visited on 09/12/2013)

 

EFSA supporting publication 2013:EN-532

 

 


 

 

2014

 

 

>>> *** Further, it was addressed that recently discussions have being held at OIE level on Chronic Wasting Disease of cervids. <<<

 

 

2012

 

 

328. Agent causing chronic wasting disease (CWD)

 

Dr Ben Jebara summarised the situation of the agent causing chronic wasting disease (CWD) which was a transmissible spongiform encephalopathy (TSE), along with other spongiform diseases, such as scrapie and bovine spongiform encephalopathy. At the present time there was no scientific evidence that the infection was transmissible to domestic animals or to humans. Two countries reported the disease present in 2011: United States of America and Canada.

 

– 104 –

 

80 GS/FR – PARIS, May 2012

 

 


 

 

 

>>> *** Further, it was addressed that recently discussions have being held at OIE level on Chronic Wasting Disease of cervids. <<<

 

 

2002 Singeltary vs O.I.E. on CWD to human risk factor ;

 

 

Subject: Re: CWD AMERICA ???

 

Date: Fri, 12 Jul 2002 19:10:18 +0200

 

From: "INFORMATION DEPT"

 

Organization: O.I.E

 

To: "Terry S. Singeltary Sr."

 

References: <3d2f0169 .3="" wt.net=""> <012901c229b2 ad43bb90="" f00000a=""> 3D2F2358.5010700@wt.net

 

I agree with you Dr Terry. The OIE, namely the International Animal Health Code Commission is working on making proposals to Member Countries to change the OIE lists so to avoid some the problems mentioned in you e-mail. This will take at least two years before adoption by the International Committee. For BSE, countries asked the OIE to post information on BSE on the OIE web site.

 

Personally, I am interested in Chronic Wasting Disease and I follow what is distributed through ProMed. Delegates of OIE Member Countries can propose diseases to be added to the list.

 

Kind regards.

 

Karim Ben Jebara

 

 


 

 

----- Original Message -----

 

From: "Terry S. Singeltary Sr."

 

To: "INFORMATION DEPT"

 

Sent: Friday, July 12, 2002 8:43 PM

 

Subject: Re: CWD AMERICA ???

 

 

>>> *** Further, it was addressed that recently discussions have being held at OIE level on Chronic Wasting Disease of cervids. <<<

 

 

> hello Dr. Jebara,

 >

 > many thanks for your swift and kind reply.

 >

 > if i am not mistaken, it was the same email address.

 > it was 3 or 4 weeks ago i wrote, as it is, i don't

 > save 'sent' emails anymore, unless very important.

 >

 > my main concern (besides the fact that a potential TSE

 > has been in the USA cattle for some time, but the APHIS

 > do not test to find), is that the CWD could very well be

 > transmitting to humans, and i just did not see to much

 > posted about it on OIE site.

 >

 > > Coming back to your question, Chronic Wasting Disease is not an OIE

 >

 > > listed disease. Please see OIE disease lists at

 >


 >

 > why is this TSE (CWD) not listed and followed as with BSE ?

 >

 > Article 1.1.3.2.

 > 1. Countries shall make available to other countries, through the

 > OIE, whatever information is necessary to minimise the spread of

 > important animal diseases and to assist in achieving better worldwide

 > control of these diseases.

 >


 >

 > The USA CWD is an important animal disease.

 >

 > why is it not followed?

 >

 > > The decision to add or delete a disease from the OIE lists, come

 >

 > > through proposals made by Member Countries and it has to be adopted by

 >

 > > the International Committee.

 >

 > i _urgently_ suggest a proposal to the OIE to follow this disease very

 > closely, and to propose _more_ testing in the USA for TSEs in the USA

 > cattle...

 >

 > kindest regards,

 > terry

 >

 > INFORMATION DEPT wrote:

 >

 > > Dear Sir,

 > >

 > > This is the first time that I receive your e-mail. To whom have you written

 > > in the OIE or to which address?

 > >

 > > Coming back to your question, Chronic Wasting Disease is not an OIE listed

 > > disease. Please see OIE disease lists at


 > >

 > > Countries should report to the OIE any disease even is not listed in the

 > > OIE's lists in some conditions (example: an exceptional epidemiological

 > > event). Please read Chapter 1.1.3 of the International animal health code to

 > > have more information on disease notification and epidemiological

 > > information agreed by OIE Member Countries at :


 > >

 > > The decision to add or delete a disease from the OIE lists, come through

 > > proposals made by Member Countries and it has to be adopted by the

 > > International Committee.

 > >

 > > Hope that I answered to your question.

 > >

 > > Best regards.

 > >

 > > Dr Karim Ben Jebara

 > > Head

 > > Animal Health Information Department

 > > OIE

 > >

 > >

 > >

 > > ----- Original Message -----

 > > From: "Terry S. Singeltary Sr."

 > > To:

 > > Sent: Friday, July 12, 2002 6:18 PM

 > > Subject: CWD AMERICA ???

 > >

 > >

 > >

 > >>I WROTE TO OIE RECENTLY ASKING 'WHY OIE DOES NOT FOLLOW CWD IN

 > >>AMERICA' ? with no reply ? i am still seeking an answer ?

 > >>

 > >>many thanks,

 > >>and kind regards,

 > >>terry

=====================

 

 


 

 

----- Original Message -----

 

From: "Terry S. Singeltary Sr."

 

To: "INFORMATION DEPT"

 

Sent: Friday, July 12, 2002 8:43 PM

 

Subject: Re: CWD AMERICA ???

 

hello Dr. Jebara,

 

many thanks for your swift and kind reply.

 

if i am not mistaken, it was the same email address. it was 3 or 4 weeks ago i wrote, as it is, i don't save 'sent' emails anymore, unless very important.

 

my main concern (besides the fact that a potential TSE has been in the USA cattle for some time, but the APHIS do not test to find), is that the CWD could very well be transmitting to humans, and i just did not see to much posted about it on OIE site.

 

Coming back to your question, Chronic Wasting Disease is not an OIE

 

listed disease. Please see OIE disease lists at

 

 


 

 

why is this TSE (CWD) not listed and followed as with BSE ?'

 

 

Article 1.1.3.2. 1. Countries shall make available to other countries, through the OIE, whatever information is necessary to minimise the spread of important animal diseases and to assist in achieving better worldwide control of these diseases.

 


 

 

The USA CWD is an important animal disease.

 

why is it not followed?

 

The decision to add or delete a disease from the OIE lists, come through proposals made by Member Countries and it has to be adopted by the International Committee.

 

i _urgently_ suggest a proposal to the OIE to follow this disease very closely, and to propose _more_ testing in the USA for TSEs in the USA cattle...

 

 

kindest regards, terry

 

END

 

 


 

 

 

>>> *** Further, it was addressed that recently discussions have being held at OIE level on Chronic Wasting Disease of cervids. <<<

 

 

*** PRICE OF CWD TSE PRION POKER GOES UP 2014 ***

 

 

Transmissible Spongiform Encephalopathy TSE PRION update January 2, 2014

 

 

*** chronic wasting disease, there was no absolute barrier to conversion of the human prion protein.

 

 

*** Furthermore, the form of human PrPres produced in this in vitro assay when seeded with CWD, resembles that found in the most common human prion disease, namely sCJD of the MM1 subtype.

 

 

Wednesday, January 01, 2014

 

Molecular Barriers to Zoonotic Transmission of Prions

 

 

*** chronic wasting disease, there was no absolute barrier to conversion of the human prion protein.

 

 

*** Furthermore, the form of human PrPres produced in this in vitro assay when seeded with CWD, resembles that found in the most common human prion disease, namely sCJD of the MM1 subtype.

 

 


 

 


 

 

*** The potential impact of prion diseases on human health was greatly magnified by the recognition that interspecies transfer of BSE to humans by beef ingestion resulted in vCJD. While changes in animal feed constituents and slaughter practices appear to have curtailed vCJD, there is concern that CWD of free-ranging deer and elk in the U.S. might also cross the species barrier. Thus, consuming venison could be a source of human prion disease. Whether BSE and CWD represent interspecies scrapie transfer or are newly arisen prion diseases is unknown. Therefore, the possibility of transmission of prion disease through other food animals cannot be ruled out. There is evidence that vCJD can be transmitted through blood transfusion. There is likely a pool of unknown size of asymptomatic individuals infected with vCJD, and there may be asymptomatic individuals infected with the CWD equivalent. These circumstances represent a potential threat to blood, blood products, and plasma supplies.

 


 

 

Friday, November 22, 2013

 

*** Wasting disease is threat to the entire UK deer population CWD TSE prion Singeltary submission

 


 

 

Wednesday, September 04, 2013

 

*** cwd - cervid captive livestock escapes, loose and on the run in the wild

 


 

 

Sunday, September 01, 2013

 

hunting over gut piles and CWD TSE prion disease

 


 

 

Wednesday, January 01, 2014

 

APHIS-2006-0118-0100 Chronic Wasting Disease Herd Certification Program and Interstate Movement of Farmed or Captive Deer, Elk, and Moose

 


 

 

Sunday, December 15, 2013

 

*** FDA PART 589 -- SUBSTANCES PROHIBITED FROM USE IN ANIMAL FOOD OR FEED VIOLATIONS OFFICIAL ACTION INDICATED OAI UPDATE DECEMBER 2013 UPDATE

 


 

 

Saturday, December 21, 2013

 

**** Complementary studies detecting classical bovine spongiform encephalopathy infectivity in jejunum, ileum and ileocaecal junction in incubating cattle ****

 


 

 

Wednesday, December 4, 2013

 

*** Bovine Spongiform Encephalopathy; Importation of Bovines and Bovine Products; Final Rule Federal Register / Vol. 78 , No. 233 / Wednesday, December 4, 2013

 


 

 

Saturday, November 2, 2013

 

*** APHIS Finalizes Bovine Import Regulations in Line with International Animal Health Standards while enhancing the spread of BSE TSE prion mad cow type disease around the Globe

 


 

 


 

 

Thursday, December 05, 2013

 

National Scrapie Eradication Program October 2013 Monthly Report Fiscal Year 2014 TSE PRION REPORT

 


 

 

Tuesday, October 29, 2013

 

VARIANT CJD PRESENTS DIFFERENTLY IN OLDER PATIENTS

 


 

 

Wednesday, October 09, 2013

 

*** WHY THE UKBSEnvCJD ONLY THEORY IS SO POPULAR IN IT'S FALLACY, £41,078,281 in compensation REVISED

 


 

 

Thursday, October 10, 2013

 

CJD REPORT 1994 increased risk for consumption of veal and venison and lamb

 


 

 

Friday, August 16, 2013

 

*** Creutzfeldt-Jakob disease (CJD) biannual update August 2013 U.K. and Contaminated blood products induce a highly atypical prion disease devoid of PrPres in primates

 


 

 

WHAT about the sporadic CJD TSE proteins ?

 

WE now know that some cases of sporadic CJD are linked to atypical BSE and atypical Scrapie, so why are not MORE concerned about the sporadic CJD, and all it’s sub-types $$$

 

Creutzfeldt-Jakob Disease CJD cases rising North America updated report August 2013

 

*** Creutzfeldt-Jakob Disease CJD cases rising North America with Canada seeing an extreme increase of 48% between 2008 and 2010 ***

 


 

 

Sunday, October 13, 2013

 

*** CJD TSE Prion Disease Cases in Texas by Year, 2003-2012

 


 

 

 

>>Our results provide compelling evidence that α-synuclein aggregates formed in the brains of MSA patients are transmissible and, as such, are prions.<<<

 

 

 

Tuesday, November 26, 2013

 

Transmission of multiple system atrophy prions to transgenic mice

 


 

 

Wednesday, May 16, 2012

 

Alzheimer’s disease and Transmissible Spongiform Encephalopathy prion disease, Iatrogenic, what if ?

 

Proposal ID: 29403

 


 

 

Tuesday, July 17, 2012

 

*** O.I.E. BSE, CWD, SCRAPIE, TSE PRION DISEASE Final Report of the 80th General Session, 20 - 25 May 2012

 


 

 

Friday, January 17, 2014

 

Taiwan Opening to Canadian beef conditional: Health Ministry BSE CJD UPDATE

 


 

 

IN A NUT SHELL ;

 

(Adopted by the International Committee of the OIE on 23 May 2006)

 

11. Information published by the OIE is derived from appropriate declarations made by the official Veterinary Services of Member Countries. The OIE is not responsible for inaccurate publication of country disease status based on inaccurate information or changes in epidemiological status or other significant events that were not promptly reported to the Central Bureau,

 


 

 

 


 

 

 

layperson

 

 

mom dod 12/14/97 confirmed hvCJD, just made a promise to mom, never forget, never let them forget. ...

 

 

 

Thursday, January 2, 2014

 

*** CWD TSE Prion in cervids to hTGmice, Heidenhain Variant Creutzfeldt-Jacob Disease MM1 genotype, and iatrogenic CJD ??? ***

 


 

 

 

 

kind regards,

 

Terry S. Singeltary Sr.

P.O. Box 42

Bacliff, Texas USA 77518